| Consolidated net profit attributable to the Company’s shareholders increased by 56% in 2025 compared to the previous year, mainly due to the following: An increase in the company’s revenue by 39% compared to the previous year. The Company achieved gross profit of SAR 327 million for the current year, representing an increase of SAR 68.9 million, or 27%, compared to the previous year. This was driven by stronger performance across the Company’s main sectors, particularly the Corporate Services sector, together with improved gross margins in the Individual Services sector as a result of higher utilization rates, enhanced operating efficiency, and cost rationalization arising from the improvement initiatives implemented during the year. A decrease of SAR 1.2 million in the provision for doubtful debts compared to the previous year, in accordance with the expected credit loss model, reflecting improved collection performance during the year. Other income increased by SAR 7 million during the current year compared to the previous year, mainly due to gains realized from the sale of one of the Company’s unutilized operational accommodation facilities during the year, in addition to government employment support for Saudi nationals. The Company realized a non-recurring capital gain from the sale of its stake in Care Shield Holding Company (an associate), amounting to SAR 105 million in December 2025. This was in line with the Company’s approach to managing its investment portfolio and achieving its investment objectives through generating returns on its investments and enhancing capital allocation efficiency in line with its strategic priorities. Finance costs decreased by SAR 3 million during the year compared to the previous year, due to lower average financing balances throughout the year. This increase in net profit for the current year was achieved despite the following: An increase of SAR 14 million in general and administrative expenses during the current year compared to the previous year, due to investment in human capital through a range of incentive programmers, training, and recruitment initiatives. An increase of SAR 8 million in sales and marketing expenses during the year, to support revenue growth. An increase in impairment loss on advances to suppliers and other receivable balances amounting to SAR 9.6 million during the year, including provisions related to the liquidation of Nabd Company. The Company’s share of profit from associate companies (Saudi Medical Systems Company “SMS” and Care Shield Holding Company) decreased by SAR 51 million compared to the previous year. This was mainly due to the non-recognition of the Company’s share of results from SMS for the second half of 2025, compared to the recognition of the full share of results for 2024, as the Company was unable to obtain the financial results of SMS. This was also affected by the decline in the share of profit from Care Shield Holding Company up to the disposal date in December 2025. It is worth noting that net profit attributable to the Company’s shareholders, after excluding the non-recurring capital gain arising from the sale of Care Shield Holding Company and the Company’s share of results from associate companies increased by 48%, equivalent to SAR 46.5 million. This reflects a significant improvement in the Company’s core operating performance and underlying profitability. |